Subtle changes in your fingers or nails may warn of lung cancer. Experts explain early signs like clubbing, swelling, and ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Discover key Q3 2025 earnings insights for Arcturus Therapeutics: pipeline progress, regulatory updates, and financial outlook.
CT scans are becoming a more commonly used tool to effectively determine a patient's future risk of heart disease and heart ...
A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a ...
Stress CMR significantly enhances diagnostic accuracy for chest pain without obstructive coronary artery disease, identifying ...
Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...
Risk stratification of patients with chest pain has traditionally focused on identifying obstructive coronary artery disease (CAD). Using this traditional approach, many symptomatic individuals are ...
There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at ...